ArticleZhongguo fei ai za zhi = Chinese journal of lung cancer2021

[Osimertinib Re-challenge for EGFR-mutant NSCLC after 
Osimertinib-induced Interstitial Lung Disease: A Case Report].

Junjie Gu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.